Our multidisciplinary team (with expertise in hepatology, gastroenterology, biochemistry, pathology, pharmacology, nutrition, immunology, microbiology, and anatomy) will continue studies on the metabolism and metabolic effects of ethanol and the mechanisms of medical disorders associated with chronic ethanol consumption. We will assess the role of gastrointestinal ADH, characterize the ethanol specific cytochrome P450 and elucidate the importance of the microsomal ethanol oxidizing system (MEOS) in primates. We will study abnormalities in hepatic aldehyde dehydrogenase activity and acetaldehyde metabolism, including its possible role in the pathogenesis of the fetal alcohol syndrome (through microtubular alterations and chromosomal abnormalities). We will assess the pathologic implications of alterations in gut flora and other mechanisms of liver injury, including effects of oxygen radicals, lipid peroxidation and disturbances in fatty acids and prostaglandin. Abnormalities in collagen synthesis and breakdown will be investigated and the response of cultured myofibroblasts and Ito cells to agents that affect collagen production will be evaluated. We plan to assess biochemical differences between alcoholics and nonalcoholics and to apply these findings to the validation of blood tests to detect heavy drinking and alcohol induced liver damage. Using our baboon model of cirrhosis as a guide, we will define precirrhotic lesions and corresponding blood changes which might allow us to recognize, at an early stage, alcoholics prone to develop cirrhosis, thereby enhancing our effectiveness in the prevention of this irreversible and potentially lethal complication. Attempts at treatment will involve agents that may counteract liver injury, including assessment of the effectiveness of hepatitis B vaccination in our alcoholic population. Alcohol-nutrition interactions will be evaluated, with emphasis on the pathogenesis of alcohol-induced pancreatic lesions, vitamin A deficiency, as well as toxicity and elucidation of a new microsomal pathway of retinol metabolism using, in part, deermice lacking alcohol dehydrogenase. The carcinogenic role of alcohol, the diagnosis of alcohol induced precancerous lesions and their prevention by beta-carotene will be studied in animal models and in alcoholics. Our ultimate goal is the application of newly acquired knowledge to the successful prevention and treatment of alcohol related diseases by permitting early diagnosis and by replacing current symptomatic therapy with rational and hopefully more effective approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA003508-13
Application #
3104551
Study Section
Special Emphasis Panel (SRCA (09))
Project Start
1977-09-26
Project End
1990-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
13
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Rosman, A S; Waraich, A; Baraona, E et al. (2000) Disulfiram treatment increases plasma and red blood cell acetaldehyde in abstinent alcoholics. Alcohol Clin Exp Res 24:958-64
Dasani, B M; Sigal, S H; Lieber, C S (1998) Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol 93:726-31
Lieber, C S (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517-44
Mokuolu, A O; Sigal, S H; Lieber, C S (1997) Gastric juice urease activity as a diagnostic test for Helicobacter pylori infection. Am J Gastroenterol 92:644-8
Lieber, C S (1997) Pathogenesis and treatment of liver fibrosis in alcoholics: 1996 update. Dig Dis 15:42-66
Cohen, P A; Mak, K M; Rosman, A S et al. (1997) Immunohistochemical determination of hepatic cytochrome P-4502E1 in formalin-fixed, paraffin-embedded sections. Alcohol Clin Exp Res 21:1057-62
Yokoyama, H; Baraona, E; Lieber, C S (1996) Molecular cloning and chromosomal localization of the ADH7 gene encoding human class IV (sigma) ADH. Genomics 31:243-5
Ma, X; Zhao, J; Lieber, C S (1996) Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. J Hepatol 24:604-13
Dohmen, K; Baraona, E; Ishibashi, H et al. (1996) Ethnic differences in gastric sigma-alcohol dehydrogenase activity and ethanol first-pass metabolism. Alcohol Clin Exp Res 20:1569-76
Puntarulo, S; Cederbaum, A I (1996) Role of cytochrome P-450 in the stimulation of microsomal production of reactive oxygen species by ferritin. Biochim Biophys Acta 1289:238-46

Showing the most recent 10 out of 229 publications